Kit d'administration de protéines BioPORTER QuikEase, pour une libération intracellulaire

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

BioPORTER^® QuikEase^™ Protein Delivery Kit has been used to deliver active granzyme B tagged with FITC into mouse neuroblastoma cell lines. Protein concentrations used for delivery were 6μg/ml which when stained for FITC-GrB yielded a 90% uptake rate.

The BioPORTER^® QuikEase^™ Protein Delivery Kit is the latest innovation in macromolecule delivery technology. It is a unique lipid-based formulation that allows for the intracellular delivery of proteins, peptides, and bioactive molecules such as enzymes and antibodies, into a broad range of cell types. The BioPORTER QuikEase kits contain individual tubes of the BioPORTER Reagent in a convenient, ready-to-use, single reaction format. Each tube contains sufficient material of the lyophilized BioPORTER Reagent to perform 1 reaction in a 6-well plate (or 35 mm dish), 4 reactions in a 24-well plate (or 16 mm wells), and 10 reactions in a 96-well plate.

BioPORTER^® QuikEase^™ Protein Delivery Kit has been used:for the delivery of single-chain antibody variable fragment (scFv) into HeLa cellsfor the transduction of QBI-293 cells with human Tau proteinfor the delivery of human granzyme B (GrB) in human cervical cancer cellsfor the delivery of epidermal fatty acid-binding protein (E-FABP) into nerve growth factor-differentiated PC12 cells (NGFDPC12)

General description

Contains 24 individual tubes of BioPORTER reagent

Legal Information

QuikEase is a trademark of Gene Therapy Systems, Inc.

BioPorter is a registered trademark of Gene Therapy Systems, Inc.